Literature DB >> 7306429

Effects of microsomal enzyme induction on paracetamol metabolism in man.

L F Prescott, J A Critchley, M Balali-Mood, B Pentland.   

Abstract

1 The metabolism of paracetamol after a single oral dose of 20 mg/kg was compared in fifteen patients with microsomal enzyme induction taking anticonvulsants or rifampicin and twelve healthy volunteers. 2 Induction was confirmed by measurement of the plasma antipyrine half-life (mean 6.4 h in the patients compared with 12.8 h in the volunteers). 3 The glucuronide conjugation of paracetamol was enhanced in the induced patients as shown by lower plasma paracetamol concentrations, a shorter paracetamol half-life, higher paracetamol glucuronide concentrations and an increased ratio of the area under the plasma concentration time curves of the glucuronide to the unchanged drug. There were no significant differences in sulphate conjugation. 4 There was a corresponding change in the pattern of urinary metabolite excretion. The induced patients excreted significantly less unchanged drug and sulphate conjugate and more glucuronide conjugate than the healthy volunteers. 5 The urinary excretion of the mercapturic acid and cysteine conjugated of paracetamol was the same in both groups. 6 Conversion of paracetamol to its potentially hepatotoxic metabolite does not seem to be increased in patients induced with anticonvulsants or rifampicin. There would seem to be no contraindication to the use of these drugs in combination.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306429      PMCID: PMC1401868          DOI: 10.1111/j.1365-2125.1981.tb01193.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy.

Authors:  J R Mitchell; S S Thorgeirsson; W Z Potter; D J Jollow; H Keiser
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

2.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.

Authors:  J R Mitchell; D J Jollow; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

3.  Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage.

Authors:  N Wrights; L F Prescott
Journal:  Scott Med J       Date:  1973-03       Impact factor: 0.729

4.  Increased paracetamol-induced hepatotoxicity after chronic alcohol consumption.

Authors:  R Teschke; G Stutz; G Strohmeyer
Journal:  Biochem Biophys Res Commun       Date:  1979-11-14       Impact factor: 3.575

5.  The effect of dichloralphenazone pretreatment on paracetamol hepatotoxicity in mice.

Authors:  A J Streeter; J A Timbrell
Journal:  Biochem Pharmacol       Date:  1979-10-01       Impact factor: 5.858

6.  High performance liquid chromatographic estimation of paracetamol metabolites in plasma.

Authors:  P I Adriaenssens; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

7.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen.

Authors:  D J Jollow; S S Thorgeirsson; W Z Potter; M Hashimoto; J R Mitchell
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

8.  Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

9.  Potentiation of acetaminophen hepatotoxicity by alcohol.

Authors:  C J McClain; J P Kromhout; F J Peterson; J L Holtzman
Journal:  JAMA       Date:  1980-07-18       Impact factor: 56.272

10.  The influence of ethanol pretreatment on the effects of nine hepatotoxic agents.

Authors:  O Strubelt; F Obermeier; C P Siegers
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-09
View more
  32 in total

1.  Phenytoin-potentiated hepatotoxicity following acetaminophen overdose? A closer look.

Authors:  Matthew D Cook; Saralyn R Williams; Richard F Clark
Journal:  Dig Dis Sci       Date:  2006-12-06       Impact factor: 3.199

2.  [Not Available].

Authors:  K Menges
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

Review 3.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

4.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

5.  Interaction of metoprolol with lorazepam and bromazepam.

Authors:  A K Scott; G A Cameron; G M Hawksworth
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

7.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 8.  Non-narcotic analgesics. Problems of overdosage.

Authors:  T J Meredith; J A Vale
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Pharmacokinetic interaction between rifampin and zidovudine.

Authors:  D M Burger; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

10.  Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism?: a case for.

Authors:  Nicholas A Buckley; Jayasri Srinivasan
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.